COMMUNIQUÉS West-GlobeNewswire

Clementia annonce l’achèvement du recrutement de l’essai MOVE, un essai de phase 3 pour la FOP
16/08/2018
Recrutement terminé quatre mois plus tôt que prévu; deux analyses des données intérimaires sont en préparation pour 2019 MONTRÉAL, 16 août 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ : CMTA), une [...]
CEPI Awards Contract Worth up to $36 million to Profectus BioSciences and Emergent BioSolutions to Develop Lassa Virus Vaccine
16/08/2018
OSLO, Norway, BALTIMORE and GAITHERSBURG, Md., Aug. 16, 2018 (GLOBE NEWSWIRE) -- CEPI (the Coalition for Epidemic Preparedness Innovations) today announced a new collaboration with Profectus BioSciences, Inc. and [...]
Treatment with ITB Therapy vs. Oral Medication Shows Quality of Life Improvement, Reduction in Spasticity-Related Pain
16/08/2018
Therapy Delivered via the Medtronic SynchroMed TM II Infusion System DUBLIN - August 16, 2018 - Medtronic plc (NYSE:MDT) today announced the online publication of 'Effect of intrathecal baclofen on pain and quality of [...]
Genetic Technologies Announces Proposed Joint Venture with Beijing Zishan Health Consultancy Limited
16/08/2018
MELBOURNE, Australia, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “ Company ”, “ GTG ”), a diversified molecular diagnostics company embracing blockchain technologies across [...]
Interim Report, Second Quarter 2018, BioPorto Group
16/08/2018
August 16, 2018 Announcement no. 14 BioPorto submits application to the FDA for clinical use of The NGAL Test™ in the US BioPorto completed the clinical studies for The NGAL Test™ in the second quarter of 2018 and has [...]
NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY - 30 JUNE 2018 (UNAUDITED)
16/08/2018
Company announcement, Helsinki, 16 August 2018 at 9:00 am NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY - 30 JUNE 201 8 (UNAUDITED) Highlights, January - June 2018 Nexstim delivered its first Navigated Brain Therapy (NBT [...]
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2018
16/08/2018
Message from the CEO The second quarter was dominated by extensive preparatory work relating to the pivotal phase III study, called “The Connection Study”. Our experience from the completed phase II study have [...]
Bavarian Nordic Announces First Half 2018 Results
16/08/2018
COPENHAGEN, Denmark, August 16, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business progress for the first half of 2018 and releases its financial calendar for [...]
H1 2018: Tecan posts strong increase in sales, driven by growth in the Partnering Business
16/08/2018
Financial results for the first half of 2018 Sales of CHF 273.5 million (H1 2017: CHF 252.2 million) Growth of 6.9% in local currencies or 8.4% in Swiss francs Strong growth in the Partnering Business Operating profit [...]
Tecan accelerates broad genomics strategy with the acquisition of NuGEN Technologies
16/08/2018
Acquisition of US-based NuGEN expands Tecan's dedicated solutions offering into new market segment of next-generation sequencing (NGS) reagents and increases overall recurring revenues NuGEN provides innovative NGS kits [...]
New Data for Fantom in Heart Attack Patients to be Presented at the TCT 2018 Conference
16/08/2018
SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, will present new data on the use of the [...]
Strongbridge Biopharma plc Announces Termination of Public Offering of Ordinary Shares
16/08/2018
DUBLIN, Ireland and TREVOSE, Pa., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) (the “Company”) today announced that it has terminated the public offering of ordinary shares previously [...]
Telix and Nihon Medi-Physics to Collaborate on Renal Cancer Imaging for the Japanese Market
16/08/2018
MELBOURNE, Australia and KYOTO, Japan and TOKYO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development [...]
The New England Journal of Medicine Publishes Two Articles on Trogarzo™
15/08/2018
Phase III results and FDA-authored article featured in latest edition of NEJM MONTREAL, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that results from the [...]
Le New England Journal of Medicine publie deux articles au sujet de Trogarzo(MC)
15/08/2018
Les résultats de phase III et un article soumis par la FDA publiés dans la plus récente édition du NEJM MONTRÉAL, 15 août 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) est heureuse d’ [...]
Kane Biotech Schedules Second Quarter 2018 Earnings Conference Call and Business Update
15/08/2018
Conference call to take place Wednesday, August 22, 2018 at 4:30pm E.T. WINNIPEG, Manitoba, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased [...]
Zomedica Announces 2018 Annual Meeting Results
15/08/2018
ANN ARBOR, Mich., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today announced that all [...]
Ascendis Pharma A/S Announces Second Quarter 2018 Financial Results and Business Update Conference Call on August 29
15/08/2018
COPENHAGEN, Denmark, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today [...]
Achillion Expands Management Team With Appointment of Anthony S. Gibney as Chief Business Officer
15/08/2018
NEW HAVEN, Conn., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) today announced the appointment of Anthony S. Gibney to the position of Executive Vice President and Chief Business [...]

Pages